Randomized Placebo-controlled Trial of Intravenous Naloxone to Improve Oxygenation in Hypoxemic Lung-Eligible Brain-Dead Organ Donors
Phase of Trial: Phase II/III
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Naloxone (Primary)
- Indications Hypoxaemia
- Focus Therapeutic Use
- Acronyms NO-HOLDS
- 25 Sep 2017 Status changed from recruiting to completed.
- 08 May 2017 Planned End Date changed from 1 Dec 2016 to 30 Jun 2017.
- 08 May 2017 Planned primary completion date changed from 1 Dec 2016 to 30 Jun 2017.